Radiotherapy dose and fractionation for stage III NSCLC.
José Belderbos
,
Iris Walraven
,
Judi van Diessen
,
Marcel Verheij
,
Dirk de Ruysscher
More about this publication
The Lancet. Oncology
Volume
16
Issue nr.
4
Pages
e156-7
Publication date
01-04-2015
Full text links
Publisher website (DOI)
10.1016/S1470-2045(15)70121-X
Europe PubMed Central
25846093
Pubmed
25846093